Monika Emilia Richter > McDermott Will & Emery Rechtsanwälte Steuerberater LLP > Frankfurt, Germany > Lawyer Profile

McDermott Will & Emery Rechtsanwälte Steuerberater LLP
Oberlindau 54-56
60323 FRANKFURT
Germany
Monika Emilia Richter photo

Work Department

Corporate Advisory

Position

Dr. Monika Richter advises national and international biotechnology/pharmaceuticals companies on various commercial legal matters related to the development, manufacturing and commercialization of medicinal products, with a particular focus on strategic alliances, research and development collaborations, license agreements, commercial manufacturing and supply agreements and distribution agreements. Her work likewise includes financing and corporate transactions as well as mergers and acquisitions.

Given her Polish background, Monika Richter is active in the Eastern European market, regularly speaking at industry conferences in Poland and advising Polish clients on several cross-border collaborations in the life sciences sector.

Read full biography: https://www.mwe.com/people/richter-monika/

Lawyer Rankings

Germany > Industry focus > Healthcare and life sciences

(Rising Stars)

Monika Emilia RichterMcDermott Will & Emery Rechtsanwälte Steuerberater LLP

McDermott Will & Emery Rechtsanwälte Steuerberater LLP‘s advisory offering focuses on three segments: project support (transactions and cooperations), regulation (market entry and licensing) and digitisation. The latter frequently pertains to the development of healthcare apps and databases, including interfacing data protection matters, a key contact here is Deniz Tschammler. Among the client roster are pharmaceutical, medical technology and biotechnology companies; the advice to healthcare funds on transactions and venture capital financing is a recent growth area. Practice head Stephan Rau specialises in M&A transactions as well as regulatory and compliance issues. He is supported by Monika Emilia Richter (implementation and advice on strategic cooperations, licensing, development agreements) and Jana Grieb, who advises pharmaceutical and medical technology companies on various issues, including research and development-related issues as well as market entry, advertising and sales. M&A expert Nadine Hartung joined Raue in March 2023.